Literature DB >> 29075067

The Effects of HFE Polymorphisms on Biochemical Parameters of Iron Status in Arab Beta-Thalassemia Patients.

Suad AlFadhli1, Matra Salem1, D K Shome2, Najat Mahdi3, Rasheeba Nizam1.   

Abstract

In this study, the potential effect of three HFE gene polymorphisms (C282Y, H63D and S65C) and the SLC40A1 A77D polymorphism on iron balance was investigated in 234 subjects (91 Arab beta-thalassemia major (BTM) patients, 34 beta-thalassemia trait (BTT) individuals and 109 health controls). Genotyping was done using restriction-fragment-length polymorphism and direct-sequencing. Serum-iron, total iron binding capacity, transferrin and ferritin were estimated in all BTT and BTM, and in 65 healthy controls. H63D was the only polymorphism detected in our cohort. Allele frequency was 13% in both BTM and BTT and 10% in controls with no significant difference. Serum iron, ferritin and transferrin saturation were significantly higher in normal males heterozygous for H63D as compared to homozygous wild-type males. Ferritin was significantly higher in BTT males with or without H63D polymorphism when compared to the healthy males with H/H genotype. No such difference was observed between H/H versus H/D BTT subgroups. We conclude that H63D is the only significant hemochromatosis-associated polymorphism in the Arabian Gulf region. The heterozygous state of H63D may significantly alter iron parameters in normal males. In BTT, it appears that the beta-thalassemia allele has an overriding influence on ferritin values, and this generally manifest in males.

Entities:  

Keywords:  Arabs; Beta-thalassemia; Ferritin; Iron; Total iron binding capacity; Transferrin

Year:  2017        PMID: 29075067      PMCID: PMC5640531          DOI: 10.1007/s12288-016-0775-7

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  31 in total

1.  Iron overload in thalassaemias and genetic haemochromatosis.

Authors:  P Aguilar-Martinez; J F Schved; C Badens; I Thuret; G Michel; M G Neonato; J Y Peltier; R Girot; S Pissard; F Galacteros; D Bachir; C Rose; M C Picot; E Denamur; J Elion
Journal:  Eur J Haematol       Date:  2000-04       Impact factor: 2.997

Review 2.  Hereditary hemochromatosis.

Authors:  Antonello Pietrangelo
Journal:  Biochim Biophys Acta       Date:  2006-05-27

3.  Serum ferritin in beta-thalassemia trait.

Authors:  A Loria; A M Konijn; C Hershko
Journal:  Isr J Med Sci       Date:  1978-11

4.  HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis.

Authors:  C Mura; O Raguenes; C Férec
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

5.  Diagnosis of hepatic iron overload: a family study illustrating pitfalls in diagnosing hemochromatosis.

Authors:  Melanie Schranz; Heribert Talasz; Ivo Graziadei; Thomas Winder; Consolato Sergi; Klaus Bogner; Wolfgang Vogel; Heinz Zoller
Journal:  Diagn Mol Pathol       Date:  2009-03

6.  The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated.

Authors:  C Borgna-Pignatti; A Solinas; C Bombieri; R Micciolo; M R Gamberini; P De Stefano; E De Menis; P F Pignatti
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

7.  [Assessment of iron status in individuals with heterozygotic beta-thalassemia].

Authors:  S F da Fonseca; E Y Kimura; J Kerbauy
Journal:  Rev Assoc Med Bras (1992)       Date:  1995 May-Jun       Impact factor: 1.209

8.  Hereditary hemochromatosis: is the gene race over?

Authors:  Paolo Gasparini; Clara Camaschella
Journal:  Eur J Hum Genet       Date:  2004-05       Impact factor: 4.246

9.  The Spectrum of beta-Thalassemia Mutations in the Arab Populations.

Authors:  Laila Zahed
Journal:  J Biomed Biotechnol       Date:  2001

10.  Frequency of the hemochromatosis gene (HFE) variants in a Jordanian Arab population and in diabetics from the same region.

Authors:  Asem Alkhateeb; Amal Uzrail; Khaldon Bodoor
Journal:  Dis Markers       Date:  2009       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.